Sequential protocol with urinary-FSH/recombinant-FSH versus standard protocol with recombinant-FSH in women of advanced age undergoing IVF

References

• West CR, Carlson NE, Lee JS, et al. Acidic mix of FSH isoforms are better facilitators of ovarian follicular maturation and E2 production than the less acidic. Endocrinology 2002;143:107–16
   PubMed Web of Science ®Google Scholar
• Baird DT. Folliculogenesis and gonadotrophins. In: Adashi EY, Baird DT, Crosignani PG, eds. Gonadotrophins and fertility in women. Rome: Serono Fertility Series; 1999:1–10
   Google Scholar
• McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000;21:200–14
   PubMed Web of Science ®Google Scholar
• Wide L, Bakos O. More basic forms of both human folliclestimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular and luteal phase. J Clin Endocrinol Metab 1993;76:885–9
   PubMed Web of Science ®Google Scholar
• Ulloa-Aguirre A, Damian-Matsumura P, Jimenez M, et al. Biological characterization of the isoforms of urinary human follicle-stimulating hormone contained in a purified commercial preparation. Hum Reprod 1992;7:1371–8
   PubMed Web of Science ®Google Scholar
• Wide L, Wide M. Higher plasma disappearance rate in the mouse for pituitary follicle-stimulating hormone of young women compared to that of men and elderly women. J Clin Endocrinol Metab 1984;58:426–9
   PubMed Web of Science ®Google Scholar
• D'Antonio M, Borrelli F, Datola A, et al. Biological characterization of recombinant human follicle stimulating hormone isoforms. Hum Reprod 1999;14:1160–7
   PubMed Web of Science ®Google Scholar
• Bergh C, Howles CM, Borg K, et al. Recombinant human follicle-stimulating hormone (r-hFSH;Gonal F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133–9
   PubMed Web of Science ®Google Scholar
• Out HJ, Driessen SG, Mannaerts BM, Coelingh Bennink HJ. Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertil Steril 1997;68:138–42
   PubMed Web of Science ®Google Scholar
• Strehler E, Abt M, El-Danasouri I, et al. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. Fertil Steril 2001;75:332–6
   PubMed Web of Science ®Google Scholar
• Hugues JN, Bry-Gauillard H, Bständig B, et al. Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer. J Ass Reprod Genet 2001;18:191–6
   PubMed Web of Science ®Google Scholar
• Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle-stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534–40
   PubMed Web of Science ®Google Scholar
• Mohamed MA, Sbracia M, Pacchiarotti A, et al. Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study. Fertil Steril 2006;85:1398–403
   PubMed Web of Science ®Google Scholar
• Pacchiarotti A, Aragona C, Gaglione R, Selman H. Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle. J Assist Reprod Genet 2007;24:400–5
   PubMed Web of Science ®Google Scholar
• Daya S, Gunby J. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999;14:2207–15
   PubMed Web of Science ®Google Scholar
• Wide L. Follicle-stimulating hormones in anterior pituitary gland from children and adults differ in relation to sex and age. J Endocrinol 1989;123:519–29
   PubMed Web of Science ®Google Scholar
• Selman H, Pacchiarotti A, El-Danasouri I. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome. Fertil Steril 2010;94:1782–6
   PubMed Web of Science ®Google Scholar
• Selman HA, De Santo M, Sterzik K, et al. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality. Fertil Steril 2002;78:1061–7
   PubMed Web of Science ®Google Scholar
• Devroey P, Tjandraprawira K, Mannaerts B, et al. A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization. Hum Reprod 1995;10:332–7
   PubMed Web of Science ®Google Scholar
• Devroey P, van Steirteghem A. A review of ten years experience of ICSI. Hum Reprod Update 2004;10:19–28
   PubMed Web of Science ®Google Scholar
• Nayudu PL, Vitt UA, Barrios De Tomasi J, et al. Intact follicle culture: what it can tell us about the roles of FSH glycoforms during follicle development. Reprod Biomed Online 2002;5:240–53
   PubMedGoogle Scholar